Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases: Findings From the NRG-BR001 Phase 1 Trial

IMPORTANCE: Stereotactic body radiotherapy (SBRT) for oligometastases is hypothesized to improve survival and is increasingly used. Little evidence supports its safe use to treat patients with multiple metastases. OBJECTIVE: To establish safety of SBRT dose schedules in patients with 3 to 4 metastas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Chmura, Steve, Winter, Kathryn A., Robinson, Clifford, Pisansky, Thomas M., Borges, Virginia, Al-Hallaq, Hania, Matuszak, Martha, Park, Sean S., Yi, Sun, Hasan, Yasmin, Bazan, Jose, Wong, Philip, Yoon, Harold A., Horton, Janet, Gan, Gregory, Milano, Michael T., Sigurdson, Elin Ruth, Moughan, Jennifer, Salama, Joseph K., White, Julia
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2021
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063134/
https://ncbi.nlm.nih.gov/pubmed/33885704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2021.0687
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars